Fatigue and Kinematics During Isometric Activity of the Upper Limbs in Young and Older Adults
30 de marzo de 2022 actualizado por: Helena Silva, Escola Superior de Saude da Cruz Vermelha Portuguesa - Lisboa
Relationship Between Perceive Effort, Physiological and Kinematic Changes During Upper Limbs Isometric Activity and Its Relationship With the Socio-demographic Characteristics
The aim of this study is to understand the relationship between perceived effort and physiological and kinematic variables caused by isometric activity of the upper limbs, as well as its relationship with socio-demographic characteristics, level of activity and quality of life.
Descripción general del estudio
Tipo de estudio
Intervencionista
Inscripción (Actual)
60
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Lisboa, Portugal, 1300-125
- Escola Superior de Saúde da Cruz Vermelha Portuguesa - Lisboa
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Healthy
- Minimum age of 18 years;
Exclusion Criteria:
- Unable to provide written consent
- History of heart, cardiovascular and / or respiratory disease,
- Known untreated hypertension, cardiomyopathy, or exercise intolerance
- Presence of cognitive or neurological disorders
- Neuromuscular or orthopaedic disorder that limits the movement of the upper limb to 90° flexion or the maintenance of that position
- BMI ≥ 40
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Isometric activity
All participants will be included in this arm
|
Participants will do elevation of upper limbs and mantain a 90º degree flexion position in an unsupported way.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from Baseline in perceived effort on the Borg category-ratio 10-point scale (CR 10)
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
The perceived effort will be measured with Borg CR 10 scale.
Possible scores range from 0 (no exertion at all) to 10 (extremely strong).
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in heart rate
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Heart rate (heart beatings per minute) measured before and during activity to track cardiovascular changes during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in respiratory rate
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Respiratory rate (respiratory cycles per minute) measured before and during activity to track changes in respiratory function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in heart rate variability (HRV)
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Interval (in milliseconds) between consecutive heartbeats measured before and during activity to track changes in autonomic function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in electrodermal activity (EDA)
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Electrical conductance (in microsiemens -µS) between two points of the hand over time measured before and during activity to track changes in autonomic function during activity.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential amplitude through surface electromyography (sEMG)
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Muscle action potential amplitude (in millivolts - ms) in surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential duration through surface electromyography (sEMG)
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Muscle action potential duration (in milliseconds - ms) in surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in muscle action potential frequency through surface electromyography (sEMG)
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Muscle action potential frequency (in hertz - Hz) of surface electromyographic signal measured before and during activity to track muscular fatigue signs.
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in respiratory pattern through inertial motion units (IMU) from baseline and during activity
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Angular range of motion (in degrees) of rib cage and abdominal wall during upper limb activity measured before and during activity to track changes in respiratory pattern during activity
|
From baseline to end of activity, up to 15 minutes
|
|
Change from Baseline in upper limb motion angular acceleration through inertial motion units (IMU) system
Periodo de tiempo: From baseline to end of activity, up to 15 minutes
|
Angular acceleration (in m/s^2) of the arm measured before and during activity to track small movements of upper limb during isometric activity
|
From baseline to end of activity, up to 15 minutes
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Health Status
Periodo de tiempo: Before isometric activity
|
Health Status will be measured with Medical Outcomes Study (MOS) Short Form Health Survey 36 Item version 2 which measure health status of populations and individuals.
Possible scores range from 0 0 (worst health status) to 100 (best health status).
|
Before isometric activity
|
|
Physical activity level
Periodo de tiempo: Before isometric activity
|
Physical activity level will be measured using European Prospective Investigation into Cancer and Nutrition Physical Activity Questionnaire (EPIC-PAQ) that allows to estimate energy expenditure through self-report assessment of the intensity and average duration (per day, week and month) of physical activity performed by the participants in three distinct dimensions (professional, domestic and leisure). Participants are classified as ACTIVE if they perform: at least 150 minutes per week of moderate physical activity; OR at least 75 minutes per week of vigorous physical activity; OR at least 150 minutes per week of a combination of moderate-intensity activity. If they don't present any of the conditions described, they will be categorized as SEDENTARY. |
Before isometric activity
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Investigadores
- Director de estudio: Daniel López López, PhD, Universidade da Coruña
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de octubre de 2021
Finalización primaria (Actual)
28 de febrero de 2022
Finalización del estudio (Actual)
28 de febrero de 2022
Fechas de registro del estudio
Enviado por primera vez
4 de junio de 2021
Primero enviado que cumplió con los criterios de control de calidad
16 de junio de 2021
Publicado por primera vez (Actual)
24 de junio de 2021
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
31 de marzo de 2022
Última actualización enviada que cumplió con los criterios de control de calidad
30 de marzo de 2022
Última verificación
1 de marzo de 2022
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- ESSCVP_FIS01/2021
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
No
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
producto fabricado y exportado desde los EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .